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In addition to their eff  ector functions, CD4 T 
lymphocytes play a major role in regulating the 
magnitude of both innate and adaptive immune 
responses. This regulatory activity has been 
traditionally attributed to distinct CD4+ T cells 
subsets. Thus, Th1 cells are known to down-
modulate Th2 cell function through their pro-
duction of IFN-γ, whereas IL-10 secretion by 
Th2 cells governs the extent of Th1 responses 
(1–3). In addition to this cross-regulation 
  between Th cell subsets, a second, more re-
cently discovered form of CD4-dependent 
suppression is that mediated by CD25+Foxp3+ 
T reg cells, which are both naturally occurring 
and/or induced as a consequence of antigen 
(Ag) stimulation (4–6).
CD4+ T cell–dependent regulation plays a 
major function in determining the outcome of 
infection. In addition to governing eff  ector 
  responses against pathogens themselves, CD4 
T lymphocytes serve a critical role in limiting 
these responses so that they do not become 
detrimental to the host. A key cytokine involved 
in both activities is IL-10. This mediator potently 
down-regulates APC functions (7–9) and is 
produced by Th2 lymphocytes (2), Tr1 cells (10), 
CD25+ (11, 12) and CD25− (13, 14) T reg 
cells, and Th1 cells (15), as well as B lymphocytes 
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Although interferon 𝗄 (IFN-𝗄) secretion is essential for control of most intracellular patho-
gens, host survival often also depends on the expression of interleukin 10 (IL-10), a cyto-
kine known to counteract IFN-𝗄 effector functions. We analyzed the source of regulatory 
IL-10 in mice infected with the protozoan parasite Toxoplasma gondii. Unexpectedly, 
IFN-𝗄–secreting T-bet+Foxp3− T helper type 1 (Th1) cells were found to be the major 
producers of IL-10 in these animals. Further analysis revealed that the same IL-10+IFN-𝗄+ 
population displayed potent effector function against the parasite while, paradoxically, also 
inducing profound suppression of IL-12 production by antigen-presenting cells. Although 
at any given time point only a fraction of the cells appeared to simultaneously produce 
IL-10 and IFN-𝗄, IL-10 production could be stimulated in IL-10−IFN-𝗄+ cells by further 
activation in vitro. In addition, experiments with T. gondii–specifi  c IL-10+IFN-𝗄+ CD4 
clones revealed that although IFN-𝗄 expression is imprinted and triggered with similar 
kinetics regardless of the state of Th1 cell activation, IL-10 secretion is induced more 
rapidly from recently activated than from resting cells. These fi  ndings indicate that IL-10 
production by CD4+ T lymphocytes need not involve a distinct regulatory Th cell subset but 
can be generated in Th1 cells as part of the effector response to intracellular pathogens.
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(16) and APCs themselves (17, 18). Consistent with the 
known suppression of Th1 eff  ector responses by IL-10, mice 
defi  cient in this cytokine have been shown to be more 
resistant to several diff  erent intracellular pathogens (19–21). 
However, in the case of several infectious agents, IL-10 KO 
animals actually display increased suscep  tibility (22–25).
An important example of the latter phenomenon occurs 
in IL-10–defi  cient mice infected with Toxoplasma gondii (22), 
an intracellular protozoan parasite that in IL-10–suffi   cient 
  animals triggers a potent Th1 response, which rapidly shuts 
down parasite growth. When infected with T. gondii, IL-10 
KO mice undergo acute mortality, which is paradoxically ac-
companied by enhanced parasite clearance. Instead, the death 
of these animals appears to stem from uncontrolled produc-
tion of proinfl  ammatory cytokines and IFN-γ, leading to se-
vere tissue pathology. Importantly, CD4+ T cells have been 
shown to play a critical role in the fatal outcome of T. gondii 
infection in IL-10 KO mice. Thus, their mortality can be 
prevented by treatments that decrease the magnitude of the 
CD4 T cell response, such as administration of anti-CD4 
mAb (22), simultaneous blockade of CD28/CD80 and 
CD40/CD40L (26), or blockade of CD28/CD80 with con-
current IL-12 neutralization (27).
Interestingly, in addition to being the major mediators of 
immunopathology in T. gondii–exposed IL-10 KO mice, 
CD4 T lymphocytes appear to be the major source of the cy-
tokine responsible for the prevention of disease in infected 
IL-10–suffi   cient animals. Thus, mice with a targeted deletion 
of IL-10 in CD4+ T cells display the same phenotype as con-
ventional IL-10 KO animals after T. gondii infection (28). 
Because Th2 cells do not arise in WT mice exposed to 
T. gondii under the conditions of systemic inoculation used in 
these experiments (29), this fi  nding suggested that the IL-10 
that protects against the immunopathologic consequences of 
toxoplasma infection is derived from either T reg or Th1 
CD4+ T cells.
In the current study, we have formally investigated the 
source of the CD4 T lymphocyte–derived IL-10 that pre-
vents T. gondii–induced acute mortality. Unexpectedly, we 
found that essentially all of the cytokine derives from con-
ventional T-bet+Foxp3− Th1 lymphocytes, the same cell 
population that displays eff  ector function against the parasite. 
Importantly, IL-10 expression by these cells is not a stable 
property and is preferentially induced after recent Ag expo-
sure. Collectively, our fi  ndings indicate that Th1 lympho-
cytes themselves are a critical source of biologically active 
IL-10 and do not represent a specialized T cell subset endowed 
with regulatory function.
RESULTS
IL-10 signaling is required for host survival during both 
the acute and chronic phases of T. gondii infection
In contrast to WT animals, IL-10 KO mice infected with 
avirulent strains of T. gondii display acute tissue pathology and 
mortality associated with overproduction of proinfl   am-
matory cytokines (22, 26, 27, 30). To determine whether this 
phenotype results solely from the absence of active IL-10–
mediated suppression as opposed to indirect developmental 
eff  ects caused by the lack of this cytokine gene, we fi  rst asked 
if IL-10–dependent signaling is also necessary for survival of 
infected WT animals and, if yes, whether this requirement 
additionally extends to chronically infected hosts. To do so, 
we treated WT mice beginning either 2 d before or 28 d after 
infection with a blocking anti–IL-10R mAb and monitored 
their survival. In contrast to animals injected with control 
mAb, which survived for the entire period of the experi-
ment, mice treated with anti–IL-10R mAb at the time of 
  infection rapidly succumbed, recapitulating the phenotype 
originally observed in infected IL-10 KO animals (Fig. 1 A). 
The same kinetics of mortality were observed when mice 
were treated with anti–IL-10R mAb during the chronic 
phase, demonstrating a protective role of the cytokine once 
latent infection has been established (Fig. 1 B). In both situa-
tions, the decreased survival of the anti–IL-10R mAb-treated 
mice was preceded by signifi  cant weight loss (Fig. 1, C and D) 
and hepatic dysfunction as indicated by increased levels of 
  serum aspartate aminotransferase (AST; Fig. 1, E and F), 
Figure 1.  IL-10R signaling is required for host survival during both 
acute and chronic infection with an avirulent strain of T. gondii. WT 
mice inoculated i.p. with 20 ME-49 cysts were treated with control (open 
circles; n = 10), anti–IL-10R (closed circles; n = 10), or anti-CD25 (open 
triangles; n = 10) mAbs either at days −2 and +2 (A, C, and E) or at days 
+28, 30, and 33 (B, D, and F). Survival (A and B) and body weight (C and D) 
of the infected mice was then monitored. In addition, levels of hepatic 
ASTs (E and F) were measured in sera of individual mice before (hatched 
bars) or after treatment with the control (open bars) or anti–IL-10R 
(shaded bars) mAbs. The results shown represent the mean ± SD for each 
group. Comparable results were obtained in two additional experiments.JEM VOL. 204, February 19, 2007  275
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consistent with previous observations in infected IL-10 
KO animals (22).
In the same experiments, parallel groups of animals were 
injected with depleting anti-CD25 mAb to assess the possible 
contribution of naturally occurring CD25+ T reg cells as a 
source of IL-10. The resulting CD25 depletion failed to aff  ect 
host survival when initiated either during acute or chronic 
infection (Fig. 1, A and B).
CD4+ T cells are a major source of host-protective IL-10 
and negatively regulate IL-12 production in acutely 
infected mice
As a consequence of T. gondii exposure, serum levels of 
IL-12p40 and IFN-γ transiently increase and peak on day 7 
after infection (21). Treatment with anti–IL-10R, but not 
anti-CD25 (not depicted), mAb resulted in further elevation 
of these two cytokines (Fig. 2). Anti–IL-10R mAb adminis-
tration also dramatically augmented levels of IL-10, probably 
as a consequence of blockade of cytokine consumption. To 
assess the contribution of CD4 T lymphocytes in the ob-
served serum cytokine responses, groups of infected mice 
were treated in parallel with either anti–IL-10R plus anti-
CD4 mAb or anti-CD4 mAb alone. Simultaneous depletion 
of CD4+ T cells completely abrogated the increases in IFN-γ 
and IL-10 resulting from anti–IL-10R mAb treatment, sug-
gesting that Th lymphocytes serve as a major source of these 
two cytokines. In contrast, ablation of CD4+ T lymphocytes 
caused only a minor decrease in serum IL-12 levels in the 
same anti–IL-10R mAb–treated animals. Unexpectedly, anti-
CD4 mAb depletion induced a sharp increase in IL-12 in in-
fected mice in the absence of concurrent anti–IL-10R mAb 
administration (Fig. 2). The latter fi   ndings suggested that 
during T. gondii infection CD4+ T cells suppress rather than 
promote IL-12 production.
To directly test this hypothesis, we reconstituted RAG × 
IL-10 double KO mice with either WT or IL-10–defi  cient 
CD4+ T cells from naive donors and infected them with 
T. gondii 7 d later. When serum cytokine levels were measured 
1 wk later, the recipients of WT, but not IL-10 KO, CD4+ 
T cells showed decreased IL-12 levels relative to the nonre-
constituted controls animals (Fig. 3 A). Although the WT 
CD4+ T cell–reconstituted mice displayed signifi  cantly in-
creased IFN-γ production relative to nonreconstituted ani-
mals, the levels observed were threefold lower than those 
measured in the recipients of IL-10 KO CD4+ T cells, prob-
ably as a consequence of the decreased IL-12 production in 
the former mice. The uncontrolled IFN-γ production ob-
served in the RAG × IL-10 KO mice reconstituted with IL-10 
KO CD4+ cells correlated with a reduction in survival rela-
tive to the infected nonreconstituted animals (Fig. 3 B). In 
contrast, RAG × IL-10 KO recipients of WT CD4+ T cells 
were protected against T. gondii–induced lethality.
The IL-10–producing CD4+ T cells in T. gondii infection 
simultaneously secrete IFN-γ and are CD25−/Foxp3−
To further analyze the dynamics and cellular basis of IFN-γ 
and IL-10 secretion during T. gondii infection, splenocytes 
were restimulated with soluble tachyzoite Ag (STAg) at dif-
ferent time points after parasite inoculation, and both cyto-
kines were measured in culture supernatants 72 h later. IFN-γ 
Figure 2.  Serum cytokine levels in T. gondii–infected mice treated 
with anti–IL-10R mAb in the presence or absence of concurrent CD4 
T cell depletion. Uninfected or infected mice treated on days −2 and +2 
relative to the time of infection with control mAb, anti–IL-10R mAb, anti–
IL-10R plus anti-CD4 mAb, or anti-CD4 mAb only were bled on day 8 after 
infection. Serum concentrations of IL-12, IFN-γ, and IL-10 were measured 
by ELISA. Bars represent the mean ± SEM of the cytokine levels in three 
to fi  ve mice per group from one representative of two experiments per-
formed. *, P < 0.05; **, P < 0.01; NS, P = 0.2.
Figure 3.  Transfer of IL-10+/+, but not IL-10−/−, CD4+ cells 
down-regulates IL-12 production in vivo and promotes survival of 
T. gondii–infected RAG × IL-10 KO mice. 15 × 106 MACS-purifi  ed CD4 
cells from either WT or IL-10 KO naive mice were adoptively transferred 
into RAG × IL-10 KO recipients. 7 d later, reconstituted (n = 5) and non-
reconstituted (n = 4) RAG × IL-10 KO animals were inoculated i.p. with 
20 pepsin-treated ME-49 cysts. (A) Mice were bled on day 8 after infec-
tion, and serum concentrations of IL-12 and IFN-γ were measured by 
ELISA. (B) Cumulative survival of each group of animals. The data shown 
are the pooled results from two independent experiments. *, P < 0.002; 
**, P < 0.001; NS, P = 0.3.276  REGULATORY FUNCTION FOR IL-10–PRODUCING TH1 CELLS | Jankovic et al.
and IL-10 were detected together at each time point exam-
ined and appeared with similar kinetics during the course of 
infection (Fig. 4 A).
To formally identify the cells secreting the two cytokines, 
we FACS-purifi  ed total CD4+, CD4+CD25+, CD4+CD25−, 
CD4+CD25−CD45RBhigh, and CD4+CD25−CD45RBlow 
populations from spleens of week 6–infected animals and an-
alyzed their proliferative responses to STAg, as well as their 
secretion of IFN-γ and IL-10. In terms of all three parame-
ters, the entire CD4 T cell response was contained in the 
CD25− subpopulation. The CD25+ fraction at this stage of 
infection was found to consist largely of Foxp3+ CD4 T lym-
phocytes (not depicted) and is likely to represent parasite Ag 
nonresponsive, naturally occurring T reg cells. Within the 
CD25− population, responsiveness was detected only in the 
Ag-experienced CD25−CD45RBlow CD4 T lymphocyte 
fraction (Fig. 4 B). We next performed intracellular cytokine 
staining (ICS) on these STAg-restimulated CD4 T lympho-
cyte cultures. Unexpectedly, only a minor percentage of the 
IL-10–producing cells were found to secrete this cytokine 
alone. Instead, IL-10+IFN-γ+ double-positive cells repre-
sented the major IL-10+ population present, constituting on 
average 15–20% of the total IFN-γ+ CD4+ T cells in the 
cultures examined (Fig. 4 C).
The above experiments involved cytokine measurements 
on lymphocytes restimulated in vitro with parasite Ag. To 
address whether IL-10+IFN-γ+ CD4+ T cells are also the 
major source of IL-10 in vivo, we performed ICS on CD4 
T lymphocytes from acutely infected mice ex vivo, where 
the frequency of activated CD44highCD62Llow CD4+ T cells 
exceeds 70 and 50% in the peritoneum and spleen, respec-
tively  (unpublished data). As shown in Fig. 5 A, IL-10+
IFN-γ+ double-producing cells represented the domi-
nant IL-10+ population present in peritoneum and spleen 
at day 7 after infection and constituted on average 10% of 
the total IFN-γ+ CD4+ T cells. This population was also 
found to predominate in the splenic CD4 T cell response to 
a second intracellular protozoan parasite, Trypanosoma cruzi 
(Fig. S1, available at http://www.jem.org/cgi/  content/full/
jem.20062175/DC1).
Because during the acute phase of T. gondii infection the 
CD25 marker, expressed on naturally occurring T reg cells, 
is also up-regulated on activated Th cell eff  ectors, we ana-
lyzed CD4+ T cells for their expression of the transcription 
factor Foxp3, a specifi  c marker of the former population. In 
acutely infected mice, Foxp3+CD4 T lymphocytes were 
barely detectable in the peritoneum, and their frequency in 
the spleen was actually decreased when compared with naive 
animals (Fig. 5 B). The absence of a substantial increase in 
the Foxp3+CD4+ T population after T. gondii infection was 
confi  rmed in an experiment using Foxp3gfp reporter mice 
(not depicted).
IL-10+IFN-𝗄+ CD4+ T lymphocytes exert 
both Th1 cell effector and regulatory activity 
on T. gondii–infected macrophages
The observation that the major IL-10–producing CD4 T 
lymphocytes in T. gondii–infected mice are also IFN-γ+ sug-
gested that they represent a subpopulation of conventional 
Th1 lymphocytes. Indeed, T. gondii inoculation was found to 
result in a dramatic increase in the frequency of T-bet+ CD4+ 
T cells both in the spleen and peritoneum at day 7 after infec-
tion (Fig. 5 B). Importantly, essentially all of the IL-10+ CD4 
T lymphocytes present in these preparations were found to 
be T-bet+ (Fig. 5, C and D), suggesting that they arise from 
the same precursors as classical Th1 cells.
To determine whether the IL-10+IFN-γ+ CD4 T lym-
phocyte subpopulation can also express eff  ector  functions 
characteristic of Th1 cells, we tested their ability to control 
Figure 4.  Phenotypic analysis of IL-10– and IFN-𝗄–producing 
CD4+ T lymphocytes derived from mice chronically infected with 
T. gondii. Mice were inoculated with T. gondii cysts, and spleen cells 
were recovered at different time points after infection. (A) IFN-γ and 
IL-10 production by bulk splenocytes 72 h after restimulation with 
STAg. The values shown are the means ± SD of the cytokine concentra-
tion in culture supernatants from three mice per group. (B) Proliferative 
and IFN-γ/IL-10 responses of FACS-sorted CD4+ T lymphocytes from 
week 6–infected mice. Total CD4+ T cells or the indicated cell subpopu-
lations were purifi  ed and restimulated with STAg in the presence of 
irradiated APCs, and thymidine incorporation and cytokine production 
were measured at 48 and 72 h, respectively. The values shown are the 
means ± SD of duplicate assays performed on cells pooled from three 
donors. (C) IL-10 and IFN-γ intracellular staining profi  les of the same 
total CD4+ and CD4+CD25− subpopulations shown in B after additional 
restimulation with PMA/ionomycin. The dot plots shown were gated on 
CD4+ cells. The results shown in each panel are representative of three 
experiments performed.JEM VOL. 204, February 19, 2007  277
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parasite growth when added to T. gondii–infected IL-10–
  defi  cient macrophages. To do so, we used IL-10gfp reporter 
mice, designated as tiger mice (31), in which an internal ribo-
some entry site GFP element was inserted into the 3′ region 
of the IL-10 gene, thus allowing us to isolate IL-10–producing 
cells ex vivo without subsequent manipulation (Fig. 6 A). As 
shown in Fig. 6 B, the CD4+CD44high GFP+ cells (which se-
creted IFN-γ and IL-10) were found to stimulate even better 
control of intracellular parasite proliferation than the 
CD4+CD44high GFP− fraction (which secreted IFN-γ alone). 
The restriction of parasite growth induced by either cell pop-
ulation correlated with the level of nitrite (NO) produced in 
the cultures (Fig. 6 B) and was inhibited by anti–IFN-γ mAb 
treatment (not depicted).
Although displaying potent eff  ector function, the IL-10+IFN-
γ+ CD4+ subpopulation clearly diff  ered from the IL-10−IFN-
γ+ CD4+ fraction in its regulatory activity. Thus, when IL-12 
production was measured in the T. gondii–infected IL-10–
  defi  cient macrophage cultures, secretion of the former cytokine 
was dramatically reduced in the presence of GFP/IL-10+ but 
not GFP/IL-10− CD4 T lymphocytes. This inhibition of IL-12 
production was dependent on IL-10R signaling, because it 
was reversed in the presence of anti–IL-10R mAb (Fig. 6 C).
Figure 5.  Phenotypic analysis of IL-10– and IFN-𝗄–producing 
CD4+ T lymphocytes freshly isolated from mice with acute T. gondii 
infection. Peritoneal and spleen lymphocytes were recovered from day 7–
infected and uninfected control mice. (A) IL-10 and IFN-γ ICS of these 
populations (pooled from three animals) after restimulation for 5 h with 
anti-CD3 mAb. The dot plots shown were gated on CD4+ cells and are 
representative of fi  ve experiments performed. (B) Frequency of Foxp3+ or 
T-bet+ CD4+ T lymphocytes in the spleen and peritoneum of naive versus 
day 7–infected mice. Bars represent the mean ± SD of assays on the 
individual animals (n = 3–5). (C) T-bet versus IL-10 expression in 
peritoneal IFN-γ+ CD4+ T cells recovered from infected mice and 
restimulated as in A. (D) Frequency of peritoneal IL-10+ CD4+ T 
lymphocytes within the IFN-γ+T-bet+ and IFN-γ−T-bet− populations in 
naive versus day 7–infected mice. Bars represent the mean ± SD of as-
says on the individual animals (n = 3). The data shown in C and D are 
representative of three experiments performed.
Figure 6.  Dual effector and regulatory functions of T. gondii–
induced IL-10+IFN-𝗄+ CD4 T lymphocytes. CD4+CD44+ GFP− and 
CD4+CD44+ GFP+ lymphocytes were purifi  ed by FACS from spleens of 
day 7–infected IL-10 GFP knock-in tiger mice (A) and cultured at the indi-
cated numbers with T. gondii–infected IL-10–defi  cient peritoneal macro-
phages. (B) At 24 h, supernatants were removed, [5,6-3H]Uracil was added 
for an additional 18 h, and isotope incorporation was measured as an 
index of parasite growth. Levels of IFN-γ and IL-10 were measured in 
culture supernatants by specifi  c ELISA and NO quantitated by the Griess 
reaction. (C) In one set of cultures, control or anti–IL-10R mAb was added 
at the initiation of the experiment, and levels of IL-12p40 were measured 
in 24-h culture supernatants. Each data point is the mean of measure-
ments performed on duplicate cultures (SD < 10%). The exp eriment 
shown in B is representative of three performed; the experiment in C is 
representative of two performed.278  REGULATORY FUNCTION FOR IL-10–PRODUCING TH1 CELLS | Jankovic et al.
IL-10−IFN-𝗄+ CD4+ T cells from infected mice acquire an 
IL-10+ phenotype after further stimulation in vitro
We next asked whether the IL-10+IFN-γ+ and IL-10−IFN-
γ+ CD4 T cells induced by T. gondii infection are discrete, 
phenotypically stable subsets or represent diff  erent steps in 
the Th1 cell diff  erentiation pathway. To do so, we isolated 
GFP/IL-10+ and GFP/IL-10− CD4+CD44high lymphocytes 
from acutely infected tiger mice (as described in Fig. 6 A) and 
restimulated both populations in vitro with plate-bound anti-
CD3 mAb. When measured by FACS, GFP expression was 
gradually acquired in the cultures initially containing GFP/
IL-10− CD4+ T cells, reaching  20% of the population by 
24 and 48 h for the peritoneal and splenic populations, re-
spectively (Fig. 7). The appearance of GFP+ cells correlated 
with the induction of IL-10 secretion as measured by ELISA, 
and parallel analysis of splenic GFP/IL-10− CD4+ T cells by 
ICS both confi  rmed the appearance of IL-10+ lymphocytes and 
demonstrated that these cells coexpress IFN-γ (not depicted). 
In control experiments, no induction of GFP expression was 
observed in anti-CD3–stimulated CD4+ cells from uninfected 
animals, confi   rming the requirement for in vivo priming 
(Fig. 7). Furthermore, no changes in GFP expression were 
observed when the GFP/IL-10+ CD4+CD44high population 
was subjected to the same in vitro stimulation (not depicted).
IL-10 production by T. gondii–specifi  c IFN-𝗄+ CD4+ T cell 
clones is dependent on their state of activation
To better understand the regulation of IL-10 production in 
T. gondii Ag-induced Th1 cells, we followed the expression 
of the cytokine in a panel of established IL-10+IFN-γ+ 
CD4+ T cell clones derived from mice multiply immunized 
with STAg (32). Preliminary experiments had shown that 
IL-10 secretion was higher in cultures freshly restimulated 
with Ag. Indeed, when kinetic experiments were performed 
on PMA/ionomycin-stimulated cultures measuring IL-10 
expression by ICS, the cytokine was found to be barely de-
tectable in resting clones (28 d after prior Ag/APC stimula-
tion) but was rapidly induced in the same recently activated 
cells (3 d after Ag/APC restimulation; Fig. 8 A). By day 7, 
however, IL-10 expression had markedly declined. In con-
trast, IFN-γ expression was comparable in clones under both 
resting and reactivated conditions.
To further examine the kinetics of IL-10 secretion in 
resting versus activated CD4+ T clones, we followed the ac-
cumulation of both IL-10 and IFN-γ in PMA and ionomycin-
stimulated cultures containing either resting or recently 
activated (day 3) cell populations. In agreement with the ICS 
data from Fig. 8 A, IL-10 production was accelerated in the 
activated cells, reaching maximum levels by 6 h (Fig. 8 B). In 
sharp contrast, IL-10 secretion by resting cells was delayed, 
requiring a full 48 h to achieve peak values. Interestingly, no 
diff  erence between resting and activated cells was observed 
when the kinetics of IFN-γ production were analyzed in the 
same cultures. These fi  ndings suggested that the capacity of 
Th1 lymphocytes to synthesize IL-10 is dependent on their 
prior state of activation. In contrast, IFN-γ inducibility ap-
pears to be a stable property of this CD4 subset.
D  I  S  C  U  S  S  I  O  N 
In the present study, we show that the IL-10 that prevents 
immunopatholgy and mortality in mice infected with T. gondii 
derives from conventional Th1 cells that acquire the ability to 
Figure 7.  In vitro induction of IL-10 expression in IL-10− CD4+ T 
cells from infected mice. CD4+CD44+ GFP− lymphocytes were purifi  ed by 
FACS from peritoneum and spleen of day 7–infected IL-10 GFP knock-in tiger 
mice (n = 2–3) and cultured in medium alone or in the presence of anti-CD3 
mAb. Control cultures consisted of anti-CD3–stimulated CD4+ T cells isolated 
from uninfected tiger mice. Induction of GFP expression was examined at 24 h 
after initiation of cultures and at 48 h for splenic population from infected 
animals. The results shown are representative of two experiments performed.JEM VOL. 204, February 19, 2007  279
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produce this cytokine as a consequence of the normal immune 
response to the parasite. Interestingly, the CD4 T lympho-
cytes that provide this regulatory function can simultaneously 
serve as eff  ector cells for NO-dependent control of parasite 
growth and do not appear to represent a distinct lineage 
or novel CD4 subset. We hypothesize that such Ag-driven 
IL-10+IFN-γ+ CD4+ T cells play a major role in immune 
regulation during infection with intracellular pathogens by 
governing the extent of APC activation and are thus func-
tionally distinct from Foxp3+CD25+ T reg cells, as well as 
other previously described CD4+ T reg cell populations.
Previous reports have indicated that T. gondii–infected 
IL-10 KO mice display markedly enhanced APC function, as 
indicated by increased proinfl  ammatory cytokine production, 
which is likely to underlie their augmented Th1 response 
and, ultimately, their acute mortality (22, 26, 27, 30). We 
show in this paper that these sequelae can be recapitulated in 
WT animals by blockade of IL-10R signaling, thus empha-
sizing the direct role of IL-10 in the prevention of parasite-
induced pathology. Moreover, we demonstrate that this 
IL-10–mediated protection is critical in both acute and chronic 
phases of T. gondii infection despite the presence of other down-
regulatory mechanisms (33–35).
The results presented in this paper support the previous 
observations of Roers et al. (28) that CD4+ T lymphocytes 
are the major source of host-protective IL-10 in T. gondii in-
fection and, furthermore, establish that IL-12p40 production 
is dramatically up-regulated in the absence of these cells. The 
latter observation was somewhat unexpected given the well-
established paradigm that CD4-dependent CD40/CD40L 
co-stimulation of APCs (36, 37) augments rather than sup-
presses IL-12 production. However, in most of the situations 
in which this positive interaction was observed, the CD4+ T 
cells involved were not secreting IL-10. Thus, our fi  ndings 
suggest that, in the appropriate setting, IL-10 production by 
CD4+ T cells can override the enhancing eff  ect of co-
  stimulation on IL-12 synthesis.
Systemic T. gondii infection typically induces a highly po-
larized Th1 cell environment in which it is diffi   cult to detect 
CD4+ lymphocytes with an IL-4–producing Th2 cell phe-
notype (29, 32). Instead, all of the CD4-derived IL-10 mea-
sured in our experiments was associated with IFN-γ–producing 
cells. CD25+ T reg cells have been described to secrete both 
IL-10 and IFN-γ (38, 12). Nevertheless, the T. gondii–
induced IL-10–producing CD4 cells studied were found to 
be both Foxp3− and, when characterized in the chronic 
phase, CD25−, and therefore are clearly distinct from natu-
rally occurring T reg cells. Moreover, they can be distin-
guished from the Foxp3− IL-10–producing CD4+ T reg cells 
characterized by Vieira et al. (14), because the latter popula-
tion does not produce IFN-γ. The additional possibility that 
these T. gondii–induced IL-10+ CD4 T lymphocytes repre-
sent Tr1 cells, an IL-10+ regulatory CD4+ subset with a het-
erogeneous cytokine production profi  le (10), is also unlikely, 
based on their developmental requirements. Thus, although 
Tr1 cells require IL-10 as well as culture with weakly acti-
vated DCs for their diff  erentiation (39, 40), the IL-10+ CD4+ 
lymphocytes studied in this paper develop even when IL-10R 
signaling is blocked (not depicted) and under the conditions 
of strong DC activation associated with T. gondii infection 
(41) and, unlike Tr1 cells, are not anergic to signaling through 
the T cell receptor (Fig. 4). Instead, our results are most con-
sistent with these cells representing conventional Th1 cells, a 
hypothesis further supported by their T-bet+ phenotype and 
in vitro eff  ector function.
IL-10+ CD4+ regulatory cells with a Th1 cell phenotype 
have been described in other settings. Stock et al. (42) used 
heat-killed Listeria to induce a population of IL-10+IFN-γ+ 
CD4+ lymphocytes, which upon transfer suppressed Th2 
cell–mediated airway hypersensitivity. However, this regulatory 
Figure 8.  Distinct kinetics of IL-10 and IFN-𝗄 secretion by T. gondii–
specifi  c CD4+ T cell clones. IL-10+IFN-γ+ T. gondii Ag-specifi  c clones 
(D 36, B 71, or Clone 2; 2 × 106 clones/ml) either in a rested state 
(28 d after last exposure to Ag) or recently activated (3 or 7 d after expo-
sure to Ag/APC) were stimulated with PMA/inonomycin, and their produc-
tion of IL-10 and IFN-γ was monitored. (A) ICS was performed after 4.5 h 
of PMA/inonomycin stimulation. The dot plots shown were gated on 
CD4+ T cells. (B) Levels of IL-10 and IFN-γ were measured in the culture 
supernatants at 6, 12, 24, and 48 h after PMA/inonomycin stimulation. 
No further increase in either cytokine was detected at 72 h. The amount 
of cytokine detected at each time point is expressed as the percentage of 
the amount detected at the 48-h plateau time point (resting cells, IFN-γ = 
211 ± 9.6 ng/ml and IL-10 = 22.6 ± 0.6 ng/ml; reactivated cells, IFN-γ = 
911 ± 17.9 ng/ml and IL-10 = 115.4 ± 0.9 ng/ml). The results shown in 
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population was characterized as Foxp3+, and its activity in 
suppressing Th1 responses was not examined. Interestingly, 
IL-10+Foxp3− CD4+ regulatory cells with a Th1 cell pheno-
type recently have been demonstrated to be induced during 
the exposure of mice to a nonhealing strain of Leishmania major 
and to play a major role in determining host susceptibility 
(see Anderson et al. [43] on p. 283 of this issue). Whether 
these cells, as well as a similar population described in an 
L. donovani infection model (44), are functionally identical to 
the T. gondii–induced cells studied in this paper remains to be 
determined. In this regard, it should be noted that we identifi  ed 
a similar IL-10+ CD4+ population in mice acutely infected 
with T. cruzi (Fig. S1), a related protozoan pathogen, and 
CD4+ T cells coexpressing IL-10+IFN-γ+ have been described 
in several other infections, including murine Mycobacterium avium 
(32) and Brucella abortus (45), as well as in short-term T cell 
clones derived from patients with M. tuberculosis (46) or 
tuberculin-positive individuals (15). That such cells have not 
been more widely recognized and characterized may stem 
from their unstable IL-10–producing phenotype in vitro.
Perhaps the most unexpected fi  nding of the present study 
is that the IL-10–producing Th1 lymphocytes arising in 
T. gondii infection simultaneously display eff  ector function in 
addition to their regulatory activity. Thus, these cells are able 
to stimulate infected macrophages to release NO and mediate 
intracellular killing of the parasite. The latter observation is 
consistent with the fi  nding that the IL-10+ subpopulation of 
Th1 lymphocytes is the same fraction that in ICS displays the 
brightest staining for IFN-γ. One interpretation is that this 
population consists of recently activated cells producing max-
imal levels of both cytokines but that the amounts of IL-10 
secreted are insuffi   cient to counteract the IFN-γ–mediated 
eff  ector activity induced. Interestingly, preexposure to IFN-γ 
has recently been shown to reprogram several suppressive 
functions triggered by IL-10 signaling in macrophages (47). 
Thus, an alternative explanation of our fi  ndings is that IFN-γ 
production in IL-10+ Th1 cells selectively blocks the sup-
pressive activity of IL-10 on parasite killing. Regardless of the 
mechanism by which Th1 cell–synthesized IL-10 fails to 
compromise microbicidal responses, our data strongly suggest 
that the major regulatory function of the cytokine in this sit-
uation is to suppress the production of IL-12, and perhaps 
other proinfl   ammatory cytokines, by APCs. This in turn 
would act as a brake on IFN-γ synthesis by CD4+ T cells 
(48–50), thereby preventing the pathological consequences 
of an uncontrolled Th1 response (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20062175/DC1).
A critical question raised by our fi  ndings, as well as those 
from other studies (15, 32, 45, 46, 51) documenting IL-10 
production by Th1 cells, concerns the mechanism regulating 
the expression of the cytokine in this population. Our previ-
ous results (32), as well as fi  ndings from preliminary experi-
ments (not depicted), indicate that the production of this 
cytokine by T. gondii–induced Th1 cells does not require 
IL-12, IL-18, IL-23, STAT4, IL-4, STAT6, or IFN-γ. Al-
though the precise signaling pathway involved remains to be 
determined, our fi   ndings strongly suggest that, under the 
conditions of pathogen priming, IL-10 synthesis in Th1 lym-
phocytes represents a step in the diff  erentiation program of 
these cells in which expression of the cytokine is delayed un-
til complete activation is achieved. In direct contrast to IFN-γ, 
secretion of IL-10 is transient, and we speculate that this 
property is the result of its dependence on the state of cellular 
activation. These conclusions are both consistent with and 
extend the fi  ndings of Shaw et al. (51), who observed that 
immediately after challenge infection, IFN-γ–producing 
CD4+ T cells from T. gondii–vaccinated mice transiently ac-
quire the capacity to simultaneously secrete IL-10.
As already noted, the major down-regulatory cytokine 
IL-10 can be produced by multiple CD4+ T lymphocyte 
populations. The immunobiological signifi  cance of this re-
dundancy is a topic of great interest. IL-10 production by 
Th2 cells appears to arm them with the capacity to suppress 
their own function as well as to cross-regulate Th1 responses 
(52, 53, 2, 15). In the case of naturally occurring CD25+CD4+ 
T reg cells, IL-10 synthesis appears to be constitutive and pri-
marily functions to control autoreactivity or, when hijacked 
by certain pathogens, to promote latent infection (21). Inter-
estingly, because previous studies have demonstrated an in-
hibitory eff  ect of TLR signaling on CD25+CD4+ T reg cell 
activity (54), their functional capacity may be limited during 
infection with agents such as T. gondii that express potent 
TLR agonist activity (41). The IL-10–producing Th1 lym-
phocytes studied here have an overlapping but distinct profi  le 
of immunoregulatory properties that allows their expansion 
in the context of strong Ag-specifi  c Th1 cell priming and 
serve the primary purpose of limiting collateral host damage 
while maintaining a potent eff  ector response. Their IL-10 
synthesis is deliberately unstable to avoid sustained suppres-
sion of eff  ector function. We speculate that these regulatory 
cells are present during a wide variety of diff  erent infections 
but will be particularly prominent in those triggering exten-
sive and highly polarized Th1 responses.
MATERIAL AND METHODS
Experimental animals. C57BL/6 and BALB/c mice were obtained from 
Taconic Farms, and C57BL/10 IL-10 KO and C57BL/6 RAG2 × IL-10 
KO mice were obtained from the NIAID contract facility maintained by the 
same supplier. IL-10 GFP knock-in tiger mice were generated in the labora-
tory of R.A. Flavell, as previously described (31), and bred as homozygotes 
for the transgene. In the characterization of these animals, GFP and IL-10 
expression were found to closely correlate in all cell populations tested (31). 
All mice were maintained at an American Association for the Accreditation 
of Laboratory Animal Care–accredited animal facility at NIAID and housed 
in accordance with the procedures outlined in the Guide for the Care and 
Use of Laboratory Animals under an animal study proposal approved by the 
NIAID Animal Care and Use Committee. Age (8–12 wk)- and sex-matched 
mice were used in all experiments.
Infection procedure and Ag preparation. T. gondii cysts from the aviru-
lent strain ME-49 were prepared from the brains of infected C57BL/6 mice. 
For experimental infections, mice were inoculated i.p. with an average of 20 
cysts/animal. When indicated in the fi  gures, cyst preparations were pepsin 
treated to eliminate potential contamination with host cells (55). Tachy-
zoites of the virulent RH strain of T. gondii were harvested from infected JEM VOL. 204, February 19, 2007  281
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monolayers of human foreskin fi  broblasts. STAg was prepared as previously 
described (56).
In vivo mAb treatment. WT mice were injected i.p. with 1 mg anti–IL-10R 
(1B1.3a) (57), anti-CD25 (PC61) (58), or control mAb (GL113) (57) on 
days −2 and +2, or on days +28, 30, and 33. In one set of experiments, 
1 mg anti-CD4 mAb (GK1.5) (59) was administered i.p. alone or together 
with 1 mg anti–IL-10R on days −2 and +2. FACS analysis on splenocytes 
from anti-CD25 mAb– or anti-CD4 mAb–treated mice performed with an 
mAb with a fi  ne specifi  city distinct from the one used for the depletion (PE-
labeled anti-CD25 mAb [clone 3C7] and anti-CD4 mAb [clone RM4-5]; 
BD Biosciences) confi  rmed a >90 and >99% depletion of CD25+CD4+ 
and CD4+ T cells, respectively.
Body weight, serum cytokine, and hepatic enzyme measurement. 
Individual mice were weighed before and every 3–4 d after infection and 
mAb treatment, and the percent change in body weight was calculated for 
each animal. On days 0 and +8, 28 and 35 infected mice were bled, and lev-
els of AST were determined using a commercial kit (Boehringer) in an auto-
matic analyzer (model 917; Hitachi). Levels of IL-12, IFN-γ, and IL-10 were 
determined by ELISA in the same samples on days 0 and +8 after infection.
Cell purifi  cation for adoptive transfer. Whole CD4+ T cells were puri-
fi  ed from spleens and lymph nodes of naive WT and IL-10 KO mice by 
negative selection (Miltenyi Biotec). For adoptive transfer, recipients 
  received 15 × 106 CD4+ cells i.v.
Cell preparation, purifi  cation, and culture conditions. Single-cell sus-
pensions (4 × 106 cells/ml) were prepared from pooled peritonea or spleens 
from naive and day 7 T. gondii–infected animals (n = 2–5). At 2, 4, and 10 
wk after infection, splenocytes from individual infected mice were cultured 
in RPMI 1640 complete medium (60) for 72 h with 5 μg/ml STAg, 
and supernatants were removed for cytokine assays. For purifi  cation  of 
CD4+, CD4+CD25−, CD4+CD25+, and CD4+CD25+CD45RBhigh and 
CD4+CD25+CD45RBlow populations, pooled splenocytes from 6 wk–
infected animals (n = 3) were stained with CyChrome-labeled anti-CD4 
(RM4-5), FITC–anti-CD45Rb (16A), and biotin–anti-CD25 (7D4) mAb 
and streptavidin-PE (all obtained from BD Biosciences) and sorted on a 
FACStarPlus/SE or a FACSAria (BD Biosciences). FACS-purifi  ed CD4+ 
subpopulations (>98%) were cultured (3 × 105 cells/200 μl) in fl  at-bottom 
96-well plates with 106 irradiated splenocytes/200 μl from naive mice, plus 
5 μg/ml STAg, and their proliferative and cytokine responses were analyzed.
In a separate set of experiments, peritoneum exudate cells (PECs) and 
splenocytes from naive and day 7–infected IL-10gfp mice were stained with 
Cy-labeled anti-CD4 (RM4-5) and APC-labeled anti-CD44 (M7; BD Bio-
sciences), and CD4+CD44+ GFP− and CD4+CD44+ GFP+ cells were puri-
fi  ed (>96%) by sorting. The two populations were tested in an in vitro 
microbicidal assay or cultured for 12, 24, and 48 h in wells coated with anti-
CD3 mAb, followed by reexamination of their GFP phenotype.
Proliferation assay. At 6 wk after infection, splenic CD4+, CD4+CD25+, 
CD4+CD25−, CD4+CD25−CD45RBhigh and CD4+CD25−CD45RBlow 
FACS-purifi  ed populations were cultured with irradiated splenocytes from 
naive mice as APCs and 5 μg/ml STAg, as described in the previous sec-
tion. After 48 h, cultures were pulsed with 0.5 μCi [3H]TdR (New England 
Nuclear) per well for 18 h, and the incorporated isotype was measured.
NO and cytokine measurements. NO2
− levels were used as an indicator 
of reactive nitrogen intermediates released in culture supernatants and were 
measured by the Griess assay (61). IFN-γ, IL-12, and IL-10 were measured 
by ELISA (62, 29, 63). The limits of detection were as follows: IFN-γ = 125 
pg/ml; IL-12 = 200 pg/ml; and IL-10 = 600 pg/ml.
Intracellular staining. Analyses of intracellular cytokine expression were 
performed either on freshly isolated PECs and splenocytes stimulated with 
anti-CD3 mAb in the presence of 10 μg/ml Brefeldin A (Sigma-Aldrich) for 
5 h, or on the same in vitro spleen cell cultures used for cytokine secretion 
assays. In the latter case, the cells received an additional 18-h incubation in 
fresh medium and were subsequently stimulated with 1 ng/ml PMA (Sigma-
Aldrich) and 1 μg/ml inonomycin (Sigma-Aldrich) for 4 h with the addition 
of Brefeldin A during the last 2 h, as previously described (60). In additional 
experiments, freshly isolated PECs and splenocytes were stained with either 
PE–anti-Foxp3 (FJK-16s; eBioscience) or FITC– or PE–anti–T-bet mAb 
(4B10; Santa Cruz Biotechnology, Inc.) using a similar protocol. Cell fl  uo-
rescence was measured with a FACScan or a FACSCalibur (BD Biosci-
ences), and data was analyzed using CELLQuest (BD Biosciences) or FlowJo 
(TreeStar, Inc.) software.
Measurement of CD4+ T cell–dependent macrophage microbicidal 
activity. Infl  ammatory macrophages were harvested from IL-10 KO mice, 
inoculated i.p. 3 d earlier with 1.5 ml 3% thioglycolate (Sigma-Aldrich). 2 × 
105 cells/100 μl were distributed in fl  at-bottom 96-well plates incubated in 
complete medium for 2 h, at which time an equal number of irradiated RH 
tachyzoites were added to each well. After an additional 2–4-h incubation, 
the plates were centrifuged (8 min at 800 RPM), and 100 μl of medium was 
replaced with the same volume containing diff  erent numbers of FACS-purifi  ed 
CD4+ T lymphocytes. The plates were incubated for a further 24 h, and aliquots 
of culture supernatants were removed for quantitation of both NO and cy-
tokines. The remaining cultures were next pulsed with 0.5 μCi [5,6-3H]Uracil 
(MP Biomedicals) per well for an additional 18 h, and the incorporated ra-
dioactivity was determined (64). The percentage of microbicidal activity was 
calculated at each cell concentration tested by determining the ratio of incor-
porated counts per minute between wells receiving CD4+ lymphocytes and 
the wells containing macrophages alone. Where indicated in the fi  gures, 10 
μg/ml control (GL113) or anti–IL-10R (1B1.3a) mAb was added to the 
cultures before the CD4+ lymphocytes.
Generation and maintenance of T. gondii–specifi  c  CD4+ T cell 
clones. FACS-purifi  ed CD4+ T cells isolated from spleens of C57BL/6 
mice immunized repeatedly with STAg (34) were cloned by limiting dilu-
tion (0.3 cells/well) in 0.1 ml cells/well in round-bottom 96-well plates 
with 3 × 105 irradiated syngeneic spleen cells and 5 μg/ml STAg (60). On 
the next day, 0.1 ml rIL-2 (20 U/ml) was added to each well. At biweekly 
intervals, the cultures were given fresh medium containing APCs and Ag, 
followed by rIL-2 48 h later. Wells containing proliferating cells were iden-
tifi  ed visually and further expanded by Ag/APC restimulation and culture 
in rIL-2–containing medium at 4-wk intervals. The resulting clones were 
characterized for their cytokine secretion profi  le by ELISA and by intra-
cellular staining and were found to display a stable phenotype over a period 
of 6 mo in culture.
Statistical analysis. The statistical signifi   cance of diff  erences  between 
means between data groups was determined using an unpaired, two-tailed 
Student’s t test.
Online supplemental material. Fig. S1 shows the coexpression of IFN-γ 
and IL-10 by CD4+, but not CD8+, T lymphocytes in mice acutely 
  infected with T. cruzi (provided by A. Rothfuchs and A. Bafi  ca, NIH, 
Bethesda, MD). Fig. S2 shows a model for the cellular dynamics and 
function of IL-10–producing Th1 lymphocytes in T. gondii infection. Online 
supplemental material is available at http://www.jem.org/cgi/  content/
full/jem.20062175/DC1.
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